ColVI myopathies: where do we stand, where do we go?
<p>Abstract</p> <p>Collagen VI myopathies, caused by mutations in the genes encoding collagen type VI (ColVI), represent a clinical continuum with Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy (BM) at each end of the spectrum, and less well-defined intermediate...
Glavni autori: | Allamand Valérie, Briñas Laura, Richard Pascale, Stojkovic Tanya, Quijano-Roy Susana, Bonne Gisèle |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
BMC
2011-09-01
|
Serija: | Skeletal Muscle |
Online pristup: | http://www.skeletalmusclejournal.com/content/1/1/30 |
Slični predmeti
-
Scoping review of brucellosis in Cameroon: Where do we stand, and where are we going?
od: Christopher G Laine, i dr.
Izdano: (2020-01-01) -
Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
od: Balázs Horváth, i dr.
Izdano: (2022-02-01) -
The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
od: Alexandra Agapidou, i dr.
Izdano: (2016-05-01) -
Nurturing longevity through natural compounds: Where do we stand, and where do we go?
od: Monika N. Todorova, i dr.
Izdano: (2024-03-01) -
Demand-side climate change mitigation: where do we stand and where do we go?
od: Felix Creutzig, i dr.
Izdano: (2024-01-01)